Document Detail

Myocardium functional recovery protection by omeprazole after ischemia-reperfusion in isolated rat hearts.
MedLine Citation:
PMID:  21103748     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To evaluate the myocardium contractility alterations of isolated hearts of rats, submitted to ischemia and reperfusion with and without administration of the omeprazole.
METHODS: Twelve Wistar breed rats with 270 g mean body weight was studied. After anesthesia by intraperitoneal injection of ketamine 10mg and xylazine 2mg, their hearts were removed and perfused with Krebs-Henseleit solution (95% of O2 and 5% of CO2, 37 ºC, 110-120 mmHg perfusion pressure, 8 mmHg ventricular diastolic pressure) in the São Francisco de Assis disposable Langendorff system model Comex Ltda, MG. The six hearts of Group I (GI) and of the Group II (GII) were submitted to 20 min ischemia and 30 min reperfusion. In GII hearts, intracoronary injection of omeprazole 200 mcg was done immediately before the ischemia period induction. The following parameters were registered after the stabilization period (t0), and after the reperfusion period (t30): heart rate (HR), coronary flow (CoF), systolic pressure (SP), +dP/dt and -dP/dt. The Kruskal-Wallis test (P<0.05) was applied to statistical analysis.
RESULTS: There were no significant differences (P>0.05) between groups among HR and CoF values. Differences (P<0.05) occurred between groups, I e II after the reperfusion period (t30) regarding systolic pressure reduced for 28.0 ± 3.6% in the control group GI and for 79.0 ± 5.9% in GII; The +dP/dtmax declined to be only 31.0 ± 5.6% in GI, preserving 99.4 ± 11.2% values in GII (P<0.05). The t30 -dP/dtmax values were GI 26.0 ± 7.3% and GII 82.0 ± 2.2% (P<0.05).
CONCLUSION: The omeprazole administration before ischemia induction significantly protected the myocardium function recovery.
Otoni Moreira Gomes; Mônica de Mônico Magalhães; Rafael Diniz Abrantes
Related Documents :
21367008 - 24 effect of culture of semen in a low pressure condition at room temperature on viabil...
21403328 - Nucleation of hcp and fcc phases in bcc iron under uniform compression: classical molec...
21140238 - Glutathione-related antioxidant defense system in elderly patients treated for hyperten...
21377928 - Severe obstructive sleep apnea impairs left ventricular diastolic function in non-obese...
2272968 - Flow-volume characteristics in the pulmonary circulation.
8238548 - Adrenergic regulation of renin secretion and renal hemodynamics during deliberate hypot...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Revista brasileira de cirurgia cardiovascular : órgão oficial da Sociedade Brasileira de Cirurgia Cardiovascular     Volume:  25     ISSN:  1678-9741     ISO Abbreviation:  Rev Bras Cir Cardiovasc     Publication Date:    2010 Jul-Sep
Date Detail:
Created Date:  2010-11-24     Completed Date:  2011-04-06     Revised Date:  2012-04-02    
Medline Journal Info:
Nlm Unique ID:  9104279     Medline TA:  Rev Bras Cir Cardiovasc     Country:  Brazil    
Other Details:
Languages:  eng; por     Pagination:  388-92     Citation Subset:  IM    
Departamento de Cirurgia, São Francisco de Assis Cardiovascular Foundation-Verdade é Jesus, Belo Horizonte, MG, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Enzyme Inhibitors / pharmacology,  therapeutic use*
Heart Rate / drug effects
Myocardial Contraction / drug effects*
Myocardial Reperfusion Injury / drug therapy*
Omeprazole / pharmacology,  therapeutic use*
Rats, Wistar
Recovery of Function / drug effects
Reg. No./Substance:
0/Enzyme Inhibitors; 73590-58-6/Omeprazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of the biological behavior of decellularized pulmonary homografts: an experimental sheep ...
Next Document:  Is it time to adopt beating-heart coronary artery bypass grafting? A review of literature.